Light Switch Bio, LLC

Richmond, VA

UEI
JY3LRMUPFQW9
CAGE
8HZB0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1704 Lakeview Ave, Richmond, VA 23220, USA
Website
lightswitchbio.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Light Switch Bio, LLC's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Light-directed therapy of squamous cell head and neck cancer with a novel dual-acting chemotherapeutic. - project… Grant · R41CA281440 National Cancer Institute $461,186

Quick answers

What is Light Switch Bio, LLC's UEI?

Light Switch Bio, LLC's Unique Entity ID (UEI) in SAM.gov is JY3LRMUPFQW9.

What is Light Switch Bio, LLC's CAGE code?

Light Switch Bio, LLC's CAGE code is 8HZB0.

What is Light Switch Bio, LLC's primary NAICS code?

Light Switch Bio, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Light Switch Bio, LLC located?

Light Switch Bio, LLC's physical address in SAM.gov is 1704 Lakeview Ave, Richmond, VA 23220, USA.

Is Light Switch Bio, LLC registered in SAM.gov?

Yes. Light Switch Bio, LLC's SAM.gov registration is active through January 14, 2027.

What is Light Switch Bio, LLC's most recent federal award?

Light Switch Bio, LLC's most recent federal grant award is Light-directed therapy of squamous cell head and neck cancer with a novel dual-acting chemotherapeutic. - project… (R41CA281440), from National Cancer Institute, on August 3, 2023.

On GovTribe

See Light Switch Bio, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login